Exclusive Licensing Agreement with University of Colorado
July 8, 2019
New Iridium have executed an Exclusive Licensing Agreement with CU Boulder for the the patent in regards to Compositions and Methods of Promoting Organic Photocatalysis.
American Chemical Society (ACS) Spring Conference
March 31 - April 4, 2019
Dr. Chern-Hooi Lim attended and presented at the ACS conference. Topics presented are:
Strongly reducing organic dihydrophenazine and phenixazine photoredox catalysts for visible light-driven synthesis of polymers and small molecules
Benzimidazoles as Metal-Free and Recyclable Hydrides for CO2 Reduction to Formate
C-N Cross-Coupling via Photoexcitation of Nickel-Amine Complexes
Destination Startup - University of Colorado
February 1, 2019
New Iridium participated in the Destination Startup programhosted by Venture Partners of CU Boulder. This program is a collaboration among Colorado's leading research universities and federal laboratories, showcasing the best technologies from the region’s innovation ecosystem.
Brent Cutcliffe joins New Iridium
May 1, 2018
Brent Cutcliffejoins as the co-founder and COO of New Iridium. He holds Bachelor and MBA from Canadian universities. Mr. Cutcliffe brings experience from over 10 years in C-suite roles and high-growth startups.
Discovery of Dihydroacridine
November 26, 2019
Dimethyl‐dihydroacridines as Photocatalysts in the Organocatalyzed ATRP of Acrylate Monomers
Webinar: Fundamentals & Applications of Photoredox Catalysts in Organic & Macromolecular Synthesis
October 29, 2019
Garret Miyake, Professor of Colorado State University and Co-Founder of New Iridium was the keynote speaker to discuss the fundamentals of photoredox catalysts application in organic synthesis. Webinar recording can be found here. This event is sponsored by Merck KGaA and MilliporeSigma.
Strongly Reducing Organic Photoredox Catalysts for Visible Light-driven Synthesis of Polymers and Small Molecules
Visible-light-driven Conversion of CO2 to CH4 with an Organic Sensitizer and an Iron Porphyrin Catalyst
Dr. David J Boston joins New Iridium
Fort Collins, CO
June 12, 2019
Dr. David J. Bostonjoins New Iridium as a lead scientist. Dr. Boston earned his Ph.D. in Inorganic Chemistry from the University of Texas at Arlington in 2013, where his dissertation topic was “Examining Ruthenium Chromophores for the Photochemical Reduction of CO2 to Methanol”. Dr. Boston holds a B.Sc. in Chemistry from Iowa State University (2006), where his undergraduate research project was in catalysis for asymmetric hydrogen transfer.
Established Lab Space in Colorado State University
Fort Collins, CO
March 1, 2019
Started leasing lab space from CSU.
Winter Conference on Medicinal & Bioorganic Chemistry (WCMBC)
Marianne Foo joins as a part-time CFO of New Iridium. Ms. Foo has a B.S. in Business Administration (Finance and Accounting) from Drexel University. Ms. Foo is a Senior Consultant for Deloitte Consulting and has over eight years experience with global clients in industries ranging from pharmaceutical to consumer and industrial products.
Awarded Colorado OEDIT Advanced Industries Grant $250,000
New Iridium attended the 2019 ARPA-E Summit. This summit brings together energy stakeholders, industry professionals and technology experts from around the world to discuss and address America’s energy challenges in new and innovative ways. This year’s event recognizes 10 years of ARPA-E making ideas into reality and sets the stage for the next decade of energy innovation.
Colorado State University (CSU) Demo Day
Fort Collins, CO
April 23, 2019
New Iridium participated in CSU Demo Day which was a premiere event that inspires and enriches the entrepreneurial community of CSU and Northern Colorado. Faculty, staff, and students, as well as alumni, business professionals, and entrepreneurs had the opportunity to engage with researchers and local emerging companies in and around our community.